Showing results (1511-1520 of 1,557) with videos related to
Sort By:
Pageof 156
Nature|November 26, 2025
Inhibitors supercharge kinase turnover through native proteolytic circuitsNatalie S Scholes, Martino Bertoni, Arnau Comajuncosa-Creus, et al.Nature|January 15, 2010
Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitorsJianming Zhang, Francisco J Adrián, Wolfgang Jahnke, et al.Cancer Cell|December 10, 2014
Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitorCamilla L Christensen, Nicholas Kwiatkowski, Brian J Abraham, et al.Molecular Cell|August 22, 2025
Expanding the druggable zinc-finger proteome defines properties of drug-induced degradationMikołaj Słabicki, Jiho Park, Radosław P Nowak, et al.Cell Reports|October 3, 2019
Synthetic Lethal Interaction of SHOC2 Depletion with MEK Inhibition in RAS-Driven CancersRita Sulahian, Jason J Kwon, Katherine H Walsh, et al.European Journal of Ophthalmology|March 6, 2021
Update and guidance on management of myopia. European Society of Ophthalmology in cooperation with International Myopia InstituteJános Németh, Beáta Tapasztó, Wagih A Aclimandos, et al.Science (New York, N.Y.)|November 27, 2025
Structural basis for the recruitment and selective phosphorylation of Akt by mTORC2Martin S Taylor, Maggie Chen, Matthew Hancock, et al.Nature Communications|February 4, 2018
Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylationYiyan Zheng, Ritika Sethi, Lingegowda S Mangala, et al.Biorxiv : the Preprint Server for Biology|February 24, 2023
Template-assisted covalent modification of DCAF16 underlies activity of BRD4 molecular glue degradersYen-Der Li, Michelle W Ma, Muhammad Murtaza Hassan, et al.Nature|March 28, 2024
Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNFSandi Radko-Juettner, Hong Yue, Jacquelyn A Myers, et al.Pageof 156